Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.19 - $3.82 $171,093 - $298,437
-78,125 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$2.93 - $4.19 $228,906 - $327,343
78,125 New
78,125 $260,000

Others Institutions Holding INVO

# of Institutions
1
Shares Held
14.1K
Call Options Held
0
Put Options Held
0

About INVO Bioscience, Inc.


  • Ticker INVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,169,700
  • Market Cap $9.86M
  • Description
  • INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
More about INVO
Track This Portfolio

Track Perritt Capital Management Inc Portfolio

Follow Perritt Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.